Designer AAV muscle up
- PMID: 34534462
- DOI: 10.1016/j.cell.2021.08.031
Designer AAV muscle up
Abstract
Directed evolution of AAV capsids has been a successful strategy for generating bespoke serotypes to target gene therapies more specifically to the intended tissue. This has now been achieved for the largest organ, skeletal muscle, by selecting for an RGD containing integrin binding heptamer in a hypervariable region of the capsid of AAV9.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests In his position at the NIH, C.G.B. serves on several scientific advisory boards (MDUK Neuromuscular Center, NeuroMyoGene Lyon, Généthon, Sarepta Therapeutics, CureCMD, CMD-IR, RYR1 Foundation, MTM and CNM Registry) and receives no personal compensation for his contributions.
Comment on
-
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species.Cell. 2021 Sep 16;184(19):4919-4938.e22. doi: 10.1016/j.cell.2021.08.028. Epub 2021 Sep 9. Cell. 2021. PMID: 34506722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
